These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23666762)

  • 1. Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease.
    Gu GJ; Lund H; Wu D; Blokzijl A; Classon C; von Euler G; Landegren U; Sunnemark D; Kamali-Moghaddam M
    Neuromolecular Med; 2013 Sep; 15(3):458-69. PubMed ID: 23666762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease.
    Gu GJ; Wu D; Lund H; Sunnemark D; Kvist AJ; Milner R; Eckersley S; Nilsson LN; Agerman K; Landegren U; Kamali-Moghaddam M
    J Alzheimers Dis; 2013; 33(3):699-713. PubMed ID: 23001711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies.
    Lund H; Gustafsson E; Svensson A; Nilsson M; Berg M; Sunnemark D; von Euler G
    Acta Neuropathol Commun; 2014 Feb; 2():22. PubMed ID: 24533944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An identification of MARK inhibitors using high throughput MALDI-TOF mass spectrometry.
    Hruba L; Polishchuk P; Das V; Hajduch M; Dzubak P
    Biomed Pharmacother; 2022 Feb; 146():112549. PubMed ID: 34923338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubule affinity-regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration.
    Oba T; Saito T; Asada A; Shimizu S; Iijima KM; Ando K
    J Biol Chem; 2020 Dec; 295(50):17138-17147. PubMed ID: 33020179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer's disease treatment.
    Sun W; Lee S; Huang X; Liu S; Inayathullah M; Kim KM; Tang H; Ashford JW; Rajadas J
    Sci Rep; 2016 Oct; 6():34784. PubMed ID: 27708431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology.
    Shiurba RA; Ishiguro K; Takahashi M; Sato K; Spooner ET; Mercken M; Yoshida R; Wheelock TR; Yanagawa H; Imahori K; Nixon RA
    Brain Res; 1996 Oct; 737(1-2):119-32. PubMed ID: 8930358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262.
    Saito T; Oba T; Shimizu S; Asada A; Iijima KM; Ando K
    Hum Mol Genet; 2019 Sep; 28(18):3062-3071. PubMed ID: 31174206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.
    Horowitz PM; Patterson KR; Guillozet-Bongaarts AL; Reynolds MR; Carroll CA; Weintraub ST; Bennett DA; Cryns VL; Berry RW; Binder LI
    J Neurosci; 2004 Sep; 24(36):7895-902. PubMed ID: 15356202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262.
    Drewes G; Trinczek B; Illenberger S; Biernat J; Schmitt-Ulms G; Meyer HE; Mandelkow EM; Mandelkow E
    J Biol Chem; 1995 Mar; 270(13):7679-88. PubMed ID: 7706316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.
    Derkinderen P; Scales TM; Hanger DP; Leung KY; Byers HL; Ward MA; Lenz C; Price C; Bird IN; Perera T; Kellie S; Williamson R; Noble W; Van Etten RA; Leroy K; Brion JP; Reynolds CH; Anderton BH
    J Neurosci; 2005 Jul; 25(28):6584-93. PubMed ID: 16014719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.
    Trinczek B; Brajenovic M; Ebneth A; Drewes G
    J Biol Chem; 2004 Feb; 279(7):5915-23. PubMed ID: 14594945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.
    Wang ZH; Liu P; Liu X; Manfredsson FP; Sandoval IM; Yu SP; Wang JZ; Ye K
    Mol Cell; 2017 Sep; 67(5):812-825.e5. PubMed ID: 28826672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau therapeutic strategies for the treatment of Alzheimer's disease.
    Churcher I
    Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases.
    Trojanowski JQ; Lee VM
    FASEB J; 1995 Dec; 9(15):1570-6. PubMed ID: 8529836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.
    Annadurai N; Agrawal K; Džubák P; Hajdúch M; Das V
    Cell Mol Life Sci; 2017 Nov; 74(22):4159-4169. PubMed ID: 28634681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease?
    Schnurra I; Bernstein HG; Riederer P; Braunewell KH
    Neurobiol Dis; 2001 Oct; 8(5):900-9. PubMed ID: 11592857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling from MARK to tau: regulation, cytoskeletal crosstalk, and pathological phosphorylation.
    Timm T; Matenia D; Li XY; Griesshaber B; Mandelkow EM
    Neurodegener Dis; 2006; 3(4-5):207-17. PubMed ID: 17047359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Aβ on synapses and dendritic spines.
    Yu W; Polepalli J; Wagh D; Rajadas J; Malenka R; Lu B
    Hum Mol Genet; 2012 Mar; 21(6):1384-90. PubMed ID: 22156579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles.
    Takahashi M; Uchikado H; Caprotti D; Weidenheim KM; Dickson DW; Ksiezak-Reding H; Pasinetti GM
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1157-69. PubMed ID: 17146290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.